MT-TI Gene Cardiomyopathy: Fatal MT-TI Related Genetic Test

Test Details:

MT-TI gene cardiomyopathy is a type of cardiomyopathy that is caused by mutations in the MT-TI gene. This gene provides instructions for making a type of RNA molecule called transfer RNA (tRNA), which is essential for protein synthesis within mitochondria.

Cardiomyopathy is a disease of the heart muscle that affects its structure and function, leading to symptoms such as fatigue, shortness of breath, and heart failure. In the case of MT-TI gene cardiomyopathy, the mutations in the MT-TI gene disrupt the normal function of tRNA, impairing protein synthesis within mitochondria and leading to mitochondrial dysfunction.

MT-TI related NGS genetic testing refers to Next-Generation Sequencing (NGS) technology used to analyze the DNA sequence of the MT-TI gene. This genetic test can identify mutations or variations in the MT-TI gene that may be associated with cardiomyopathy. By detecting these mutations, the test can help diagnose MT-TI gene cardiomyopathy and provide valuable information for treatment and management of the condition.

It is important to note that MT-TI gene cardiomyopathy is a fatal condition, meaning it can lead to severe complications and premature death. Early diagnosis through genetic testing can help guide appropriate medical interventions and monitoring to improve patient outcomes.

Test Name: MT-TI Gene Cardiomyopathy

Components:

• Price: 4400.0 AED
• Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
• Report Delivery: 3 to 4 Weeks
• Method: NGS Technology
• Test Type: Cardiovascular Pneumology Disorders
• Doctor: Cardiologist
• Test Department: Genetics

Pre Test Information:

Clinical History of Patient who is going for MT-TI Gene Cardiomyopathy, fatal, MT-TI related NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with MT-TI Gene Cardiomyopathy, fatal, MT-TI related NGS Genetic DNA Test gene MT-TI.